# US Perfusion Imaging Market > US Perfusion Imaging Market Research Report By Modality (Computed Tomography (CT Scan), Magnetic Resonance Imaging (MRI), Nuclear Medicine) and By Application (Myocardial Perfusion Imaging, Ventilation Perfusion Imaging, Functional Brain Imaging) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 3.75% - **2024:** $ 1,166.1 Million - **2025:** $ 1,209.83 Million - **2035:** $ 1,748.62 Million - **Key Players:** Siemens Healthineers (DE), GE Healthcare (GB), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings Corporation (JP), Hitachi Medical Corporation (JP), Bracco Imaging S.p.A. (IT), Medtronic (IE), Elekta AB (SE) **Report ID:** MRFR/MED/17954-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-perfusion-imaging-market-19501 --- ## Market Summary ## **US Perfusion Imaging Market Overview** As per MRFR analysis, the US Perfusion Imaging Market Size was estimated at 1.2 (USD Billion) in 2023. The US Perfusion Imaging Market Industry is expected to grow from 1.26(USD Billion) in 2024 to 1.88 (USD Billion) by 2035. The US Perfusion Imaging Market CAGR (growth rate) is expected to be around 3.752% during the forecast period (2025 - 2035). ### **Key US Perfusion Imaging Market Trends Highlighted** The US Perfusion Imaging Market is currently being driven by several key factors that emphasize the necessity of advanced imaging technologies in healthcare. An increasing prevalence of cardiovascular diseases, stroke incidences, and cancer has led to a higher demand for precise diagnostic methods such as perfusion imaging. Furthermore, the emphasis on minimally invasive procedures supports the growth of this market as healthcare institutions seek to enhance patient outcomes. Moreover, technological advancements, including the integration of artificial intelligence and machine learning in imaging software, are paving the way for improved image analysis and interpretation, thereby facilitating faster clinical decisions. Opportunities in the US Perfusion Imaging Market are centered around the ongoing development of innovative imaging modalities and the adaptation of existing systems to include more sophisticated features. The increasing focus on personalized medicine opens avenues for custom-tailored imaging solutions that cater to individual patient needs. Additionally, partnerships between technology developers and healthcare providers can result in the acceleration of research initiatives that aim to enhance image quality and diagnostic accuracy. Recent trends in the US show that there is a growing acceptance of hybrid imaging systems that combine modalities like PET and CT for comprehensive assessments, which ultimately aids in better treatment planning. As healthcare providers in the region adapt to value-based care models, the utilization of perfusion imaging will likely rise, enhancing patient management and monitoring processes. Ongoing training and education about these innovative technologies are becoming integral so that medical professionals can maximize the benefits of perfusion imaging in their practices. Overall, the convergence of technology, patient-centric approaches, and evolving healthcare methodologies is shaping the US Perfusion Imaging Market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **US Perfusion Imaging Market Drivers** #### **Rising Incidence of Cardiovascular Diseases** The prevalence of cardiovascular diseases is a significant driver of growth in the US [Perfusion Imaging Market](../../../reports/perfusion-imaging-market-3511) Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 697,000 Americans died from heart disease in 2020, accounting for roughly one in every five deaths. As the population continues to age and lifestyle diseases become more prominent, the need for advanced imaging technologies, such as perfusion imaging, is expected to grow. Healthcare institutions like the American Heart Association are actively promoting awareness and research initiatives to combat these diseases, thus increasing the demand for higher-quality imaging solutions that can assess cardiac health effectively. This uptick in the patient population requiring regular diagnostic imaging can lead to significant market growth as early detection and management of cardiovascular conditions become paramount. #### **Technological Advancements in Imaging Modalities** Technological improvements in imaging modalities are substantially influencing the US Perfusion Imaging Market Industry. Innovations such as faster and more accurate magnetic resonance imaging (MRI) and computed tomography (CT) machines have resulted in enhanced perfusion imaging capabilities. The introduction of 3D imaging and artificial intelligence (AI) algorithms has further automated and improved diagnostic accuracy. According to the Radiological Society of North America (RSNA), advancements in imaging technology have shown a potential reduction of up to 30% in diagnosis time, leading to increased efficiency in medical diagnostics. Major companies including Siemens Healthineers and GE Healthcare are at the forefront of these advancements, driving the need for adoption across healthcare institutions in the United States. #### **Increase in the Number of Diagnostic Imaging Centers** The number of diagnostic imaging centers in the United States is increasing, which bodes well for the US Perfusion Imaging Market Industry. The American College of Radiology reports that more than 10,000 imaging facilities operate across the country, providing advanced imaging services including perfusion imaging. This growth can largely be attributed to the demand for outpatient services and the push for more accessible healthcare. As more facilities invest in cutting-edge imaging technologies, including those for cardiac and neurological assessments, the market for perfusion imaging is expected to expand. This trend is further bolstered by government policies that promote preventive care and early diagnosis, leading to an increased patient flow toward these specialized imaging centers. ### **US Perfusion Imaging Market Segment Insights** #### **Perfusion Imaging Market Modality Insights** The Modality segment within the US Perfusion Imaging Market represents a crucial aspect of cardiovascular imaging, significantly contributing to diagnostic accuracy and enhancing patient outcomes. This segment encapsulates a variety of advanced imaging techniques, notably Computed Tomography (CT Scan), Magnetic Resonance Imaging (MRI), and Nuclear Medicine, each playing a vital role in assessing blood flow and tissue perfusion. CT scans are widely recognized for their high-speed imaging capabilities and are often utilized in emergency settings, providing quick and detailed visualizations of vascular structures, which enhances decision-making processes in acute care scenarios. On the other hand, MRI offers non-invasive and detailed images of soft tissues, making it especially advantageous for visualizing cardiac anatomy and perfusion abnormalities without the use of ionizing radiation, thus ensuring the safety of patients, especially among sensitive populations. Meanwhile, Nuclear Medicine provides unique functional imaging that can effectively gauge blood flow and metabolic activity, allowing clinicians to evaluate physiological changes that accompany various cardiovascular diseases. This diversity in modalities contributes to the comprehensive understanding of cardiovascular health and diseases, driving growth in this market segment. The increasing prevalence of cardiovascular diseases in the US further underscores the importance of these imaging modalities, as they enhance the diagnosis and management of conditions such as coronary artery disease and congestive heart failure. Additionally, technological advancements and the integration of artificial intelligence in these modalities are revolutionizing the imaging landscape, streamlining diagnostic workflows, and improving accuracy. The significance of this segment lies not only in its current utilization but also in its potential for innovation and improvement in patient care pathways, making it a focal point in the US Perfusion Imaging Market landscape. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review #### **Perfusion Imaging Market Application Insights** The US Perfusion Imaging Market, under the Application segment, exhibits significant relevance in the healthcare landscape, particularly regarding the assessment and diagnosis of various cardiovascular and neurological diseases. Myocardial Perfusion Imaging plays a crucial role in evaluating heart conditions by helping clinicians identify areas of reduced blood flow, which can guide treatment decisions for patients with coronary artery disease. Ventilation Perfusion Imaging is also important for assessing pulmonary conditions, aiding in the diagnosis of diseases such as pulmonary embolism and other respiratory disorders. Functional Brain Imaging enhances the understanding of cerebral blood flow in patients with neurological disorders, making it a vital tool for detecting and managing conditions like stroke and dementia. The growing prevalence of cardiovascular and neurological disorders in the US drives the demand for these imaging applications, reflecting a trend towards more personalized and effective patient care. As the population ages and the incidence of these diseases rises, the emphasis on accurate detection and monitoring through perfusion imaging will likely result in advancements and innovations in this field, positioning the US Perfusion Imaging Market as a pivotal component in modern medical diagnostics. ### **US Perfusion Imaging Market Key Players and Competitive Insights** The US Perfusion Imaging Market is characterized by a diverse array of players, each vying for a foothold in an area critical to diagnostics and patient care. As advancements in imaging technologies continue to evolve, companies are navigating an increasingly competitive landscape. The focus on improving diagnostic accuracy, optimizing procedural workflows, and enhancing patient experiences is driving innovation in perfusion imaging. Fragmented yet significant, the market encompasses a variety of imaging modalities and services, with companies consistently pushing the boundaries to offer superior product offerings and integrate cutting-edge technologies. The competitive dynamics are shaped by factors such as regulatory challenges, technological advancements, and strategic collaborations that enhance market positioning and customer reach. #### Konica Minolta Healthcare Konica Minolta Healthcare has established a strong presence in the US perfusion imaging market, leveraging its expertise in imaging technology and commitment to innovation. The company is recognized for its advanced imaging solutions that cater specifically to the needs of healthcare professionals and institutions. One of the notable strengths of Konica Minolta Healthcare is its comprehensive portfolio, which includes cutting-edge diagnostic imaging systems and software solutions that enhance imaging processes. Their focus on customer satisfaction and ongoing technological advancements allows for a competitive edge in delivering better diagnostic tools and improving patient outcomes. By aligning its strategic goals with emerging healthcare trends, Konica Minolta Healthcare is effectively positioning itself to capitalize on the growing demand for perfusion imaging capabilities in the US market. #### Fujifilm Healthcare Fujifilm Healthcare also plays a significant role in the US perfusion imaging landscape, known for its robust product offerings and innovative imaging solutions. The company has a strong market presence driven by its well-established reputation for quality and reliability in imaging technologies. Fujifilm Healthcare's portfolio includes advanced imaging systems, diagnostic software, and services that are pivotal in clinical settings. The company’s strengths lie in its ability to integrate cutting-edge technology with user-friendly interfaces, improving both accessibility and functionality for users. Moreover, Fujifilm Healthcare's strategic mergers and acquisitions have allowed it to enhance its capabilities and expand its reach in the US perfusion imaging sector. By continuously investing in research and development and aligning its product offerings with the needs of the market, Fujifilm Healthcare remains competitive in this evolving landscape. #### Key Companies in the US Perfusion Imaging Market Include Konica Minolta Healthcare Fujifilm Healthcare [Medtronic](https://europe.medtronic.com/xd-en/healthcare-professionals/therapies-procedures/cardiovascular/perfusion.html) Samsung Medison Shenzhen Mindray BioMedical Electronics Elekta Siemens Healthineers Bracco Imaging GE Healthcare Canon Medical Systems Toshiba Medical Systems Hitachi Medical Systems 3M Health Care Carestream Health Philips Healthcare ### **US Perfusion Imaging Market Industry Developments** The US Perfusion Imaging Market has seen significant advancements recently, with companies like Siemens Healthineers, GE Healthcare, and Philips Healthcare leading innovations in imaging technologies. In August 2023, Medtronic announced a partnership with Philips Healthcare to enhance perfusion imaging capabilities for cardiac applications, which is expected to improve diagnostic accuracy. In terms of mergers and acquisitions, in September 2023, Fujifilm Healthcare acquired a niche imaging technology firm, expanding its portfolio in the perfusion imaging sector; this acquisition has been well-received in the market, prompting optimism about enhanced product offerings. Additionally, the growth in this market is reflected in the increased investment in Research and Development activities by major players such as Bracco Imaging and Canon Medical Systems, aiming to enhance image quality and reduce patient exposure to radiation. Over the past 2-3 years, regulatory support from the US Food and Drug Administration has accelerated the adoption of advanced imaging technologies, enabling healthcare providers to deliver more precise and timely diagnostic services. Enhanced focus on patient-centric imaging solutions and growing reimbursement rates for perfusion imaging procedures are also contributing to the market's expansion. ### **US Perfusion Imaging Market Segmentation Insights** #### **Perfusion Imaging Market Modality Outlook** Computed Tomography (CT Scan) Magnetic Resonance Imaging (MRI) Nuclear Medicine #### **Perfusion Imaging Market Application Outlook** Myocardial Perfusion Imaging Ventilation Perfusion Imaging Functional Brain Imaging ## Market Drivers ### Rising Awareness of Early Disease Detection Growing awareness of early disease detection is a crucial driver for the perfusion imaging market. Educational campaigns and initiatives by healthcare organizations are emphasizing the benefits of early diagnosis in improving treatment outcomes. As patients become more informed about cardiovascular health, they are more likely to seek diagnostic imaging services. This trend is further supported by the increasing availability of health insurance coverage for imaging procedures, making them more accessible to a broader population. As awareness continues to rise, the demand for perfusion imaging is expected to grow, as it provides critical information for early intervention and management of cardiovascular diseases. The market may see a surge in utilization as healthcare providers respond to this heightened awareness. ### Rising Incidence of Cardiovascular Diseases The increasing prevalence of cardiovascular diseases in the US is a primary driver for the perfusion imaging market. According to the American Heart Association, cardiovascular diseases account for approximately 697,000 deaths annually, highlighting the urgent need for effective diagnostic tools. Perfusion imaging plays a crucial role in assessing blood flow and identifying areas of ischemia, thereby facilitating timely interventions. As healthcare providers seek to improve patient outcomes, the demand for advanced imaging techniques is likely to rise. This trend is further supported by the growing aging population, which is more susceptible to heart-related conditions. Consequently, the perfusion imaging market is expected to experience substantial growth as healthcare systems prioritize early detection and management of cardiovascular diseases. ### Technological Innovations in Imaging Techniques Technological advancements in imaging modalities are significantly influencing the perfusion imaging market. Innovations such as hybrid imaging systems, including PET/CT and SPECT/CT, enhance the accuracy and efficiency of perfusion assessments. These systems allow for simultaneous anatomical and functional imaging, providing comprehensive insights into cardiovascular health. Furthermore, the integration of artificial intelligence and machine learning algorithms into imaging software is streamlining image analysis, reducing interpretation time, and improving diagnostic precision. As these technologies become more accessible, healthcare facilities are likely to adopt them, driving the growth of the perfusion imaging market. The market is projected to expand. Providers are investing in state-of-the-art imaging solutions to meet the increasing demand for accurate and timely diagnostics. ### Increased Investment in Healthcare Infrastructure The ongoing investment in healthcare infrastructure in the US is likely to bolster the perfusion imaging market. Government initiatives and private sector funding are directed towards enhancing healthcare facilities, particularly in underserved areas. This expansion includes the acquisition of advanced imaging technologies, which are essential for accurate diagnostics and treatment planning. As hospitals and clinics upgrade their equipment, the demand for perfusion imaging systems is expected to increase. Additionally, the emphasis on improving healthcare access and quality aligns with the growing need for effective diagnostic tools. Consequently, the perfusion imaging market may experience growth as healthcare providers seek to enhance their diagnostic capabilities and improve patient care. ### Growing Demand for Non-Invasive Diagnostic Procedures The shift towards non-invasive diagnostic methods significantly propels the perfusion imaging market. Patients and healthcare providers increasingly prefer non-invasive techniques due to their lower risk profiles and reduced recovery times. Perfusion imaging, being a non-invasive procedure, aligns with this trend, offering valuable insights into blood flow without the need for invasive interventions. This preference is particularly evident in the management of cardiovascular diseases, where timely and accurate diagnosis is critical. As awareness of the benefits of non-invasive imaging grows, the demand for perfusion imaging is expected to rise. The market may witness an increase in adoption rates. Healthcare systems are prioritizing patient safety and comfort while ensuring effective diagnostic capabilities. ## Future Outlook The [Perfusion Imaging Market](https://www.marketresearchfuture.com/reports/perfusion-imaging-market-3511) is projected to grow at a 3.75% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of cardiovascular diseases, and rising demand for non-invasive diagnostic methods. **New opportunities:** - Development of AI-driven imaging software for enhanced diagnostic accuracy. - Expansion of portable perfusion imaging devices for remote patient monitoring. - Partnerships with telehealth platforms to integrate imaging services into virtual care. By 2035, the perfusion imaging market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Type: Computed Tomography (C.T. Scan) (Largest) vs. Magnetic Resonance Imaging (MRI) (Fastest-Growing) The market share distribution among the segment values in the US perfusion imaging market reveals that Computed Tomography (C.T. Scan) holds the largest share, primarily due to its widespread adoption in clinical settings and reliability in diagnostic imaging. Meanwhile, Magnetic Resonance Imaging (MRI) is rapidly gaining traction and is projected to grow at the fastest rate, driven by advancements in imaging technology and increasing demand for non-invasive diagnostic tools. Nuclear Medicine occupies a niche position, complementing these imaging modalities with its unique capabilities but trailing in market share. Growth trends in the US perfusion imaging market are being significantly influenced by technological advancements and the increasing prevalence of chronic diseases that necessitate advanced imaging techniques. The rise in awareness regarding early diagnosis and the effectiveness of MRI in soft tissue imaging are key drivers for its rapid growth. In contrast, while C.T. Scans remain essential for quick and accurate assessments, their growth is steady rather than explosive, indicating a mature market with established usage protocols. Nuclear Medicine continues to play a critical role in specific applications but lacks the robust growth trajectory of MRI. Computed Tomography (C.T. Scan) (Dominant) vs. Magnetic Resonance Imaging (MRI) (Emerging) Computed Tomography (C.T. Scan) is the dominant imaging modality in the US perfusion imaging market, characterized by its speed, accuracy, and effectiveness in diagnosing a variety of conditions. It is widely utilized in emergency cases due to the efficiency of image acquisition and interpretation, which is crucial for timely patient management. On the other hand, Magnetic Resonance Imaging (MRI) is an emerging modality that is making significant inroads due to its superior imaging capability for soft tissues and the lack of ionizing radiation. The growing emphasis on patient safety and the development of advanced MRI techniques, such as functional MRI, is propelling its adoption and driving growth, positioning it as a formidable contender in the market. ### By Application: Myocardial Perfusion Imaging (Largest) vs. Functional Brain Imaging (Fastest-Growing) In the US perfusion imaging market, Myocardial Perfusion Imaging dominates the application segment with significant market share. This modality is pivotal in cardiovascular diagnostics, ensuring that it represents a major contributor to the overall performance of the segment. Meanwhile, Ventilation Perfusion Imaging holds a moderate position, serving as a complementary technique for lung assessments, showcasing its importance in specific clinical scenarios. The growth trends in the application segment reveal an increasing demand for advanced imaging technologies, particularly for Functional Brain Imaging, which is emerging rapidly due to the rising prevalence of neurological disorders. Enhanced government funding and substantial investments in research and development are further propelling growth, leading to innovations that boost clinical efficacy and patient outcomes. Myocardial Perfusion Imaging (Dominant) vs. Ventilation Perfusion Imaging (Emerging) Myocardial Perfusion Imaging is the dominant application in the US perfusion imaging market due to its critical role in diagnosing heart conditions and assessing myocardial blood flow. This technique utilizes various imaging modalities, including SPECT and PET, making it integral to cardiac health monitoring. On the other hand, Ventilation Perfusion Imaging is emerging as a vital component in pulmonary diagnostics, particularly in evaluating conditions like pulmonary embolism. As healthcare continues to evolve, both segments are expected to leverage technological advancements, but Myocardial Perfusion Imaging will likely remain the cornerstone of cardiac assessments while Ventilation Perfusion Imaging gains traction in specific clinical practices. ## Competitive Benchmarking The perfusion imaging market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for precise diagnostic tools. Key players such as Siemens Healthineers (Germany), GE Healthcare (United Kingdom), and Philips Healthcare (Netherlands) are at the forefront, each adopting distinct strategies to enhance their market presence. Siemens Healthineers (Germany) focuses on innovation, particularly in AI-driven imaging solutions, which positions it as a leader in advanced diagnostic capabilities. Meanwhile, GE Healthcare (United Kingdom) emphasizes strategic partnerships to expand its product offerings and enhance service delivery, thereby strengthening its competitive edge. Philips Healthcare (Netherlands) is actively pursuing digital transformation initiatives, integrating cloud-based solutions to improve workflow efficiency and patient outcomes. Collectively, these strategies contribute to a competitive environment that is increasingly centered around technological innovation and enhanced service delivery.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to respond swiftly to market demands. The competitive structure of the perfusion imaging market is moderately fragmented, with several key players influencing various segments. This fragmentation allows for diverse offerings, yet the collective impact of major companies shapes market dynamics significantly, as they vie for leadership through innovation and strategic collaborations. In October Siemens Healthineers (Germany) announced the launch of a new AI-powered perfusion imaging system designed to enhance diagnostic accuracy in cardiac assessments. This strategic move underscores the company's commitment to leveraging cutting-edge technology to improve patient care and streamline clinical workflows. The introduction of this system is likely to reinforce Siemens' position as a leader in the market, appealing to healthcare providers seeking advanced imaging solutions. In September GE Healthcare (United Kingdom) entered into a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its perfusion imaging systems. This collaboration aims to enhance patient engagement and facilitate timely interventions, reflecting GE's strategy to adapt to evolving healthcare delivery models. Such partnerships may prove crucial in expanding GE's market reach and improving patient outcomes through innovative service delivery. In August Philips Healthcare (Netherlands) unveiled a new cloud-based platform that integrates perfusion imaging data with electronic health records (EHRs). This initiative is indicative of Philips' focus on digital transformation, aiming to provide healthcare professionals with comprehensive patient insights. By enhancing interoperability, Philips is likely to improve clinical decision-making and foster a more integrated approach to patient care. As of November current trends in the perfusion imaging market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are shaping the competitive landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition towards a focus on technological advancements, reliability in supply chains, and the ability to deliver superior patient outcomes. This transition suggests that companies prioritizing innovation and strategic partnerships will likely emerge as leaders in the evolving market. ## Recent News & Developments The US Perfusion Imaging Market has seen significant advancements recently, with companies like Siemens Healthineers, GE Healthcare, and Philips Healthcare leading innovations in imaging technologies. In August 2023, Medtronic announced a partnership with Philips Healthcare to enhance perfusion imaging capabilities for cardiac applications, which is expected to improve diagnostic accuracy. In terms of mergers and acquisitions, in September 2023, Fujifilm Healthcare acquired a niche imaging technology firm, expanding its portfolio in the perfusion imaging sector; this acquisition has been well-received in the market, prompting optimism about enhanced product offerings. Additionally, the growth in this market is reflected in the increased investment in Research and Development activities by major players such as Bracco Imaging and Canon Medical Systems, aiming to enhance image quality and reduce patient exposure to radiation. Over the past 2-3 years, regulatory support from the US Food and Drug Administration has accelerated the adoption of advanced imaging technologies, enabling healthcare providers to deliver more precise and timely diagnostic services. Enhanced focus on patient-centric imaging solutions and growing reimbursement rates for perfusion imaging procedures are also contributing to the market's expansion. ## Report Scope | MARKET SIZE 2024 | 1166.1(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1209.83(USD Million) | | MARKET SIZE 2035 | 1748.62(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.75% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Siemens Healthineers (DE), GE Healthcare (GB), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings Corporation (JP), Hitachi Medical Corporation (JP), Bracco Imaging S.p.A. (IT), Medtronic (IE), Elekta AB (SE) | | Segments Covered | Type, Application | | Key Market Opportunities | Advancements in artificial intelligence enhance diagnostic accuracy in the perfusion imaging market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the perfusion imaging market, enhancing diagnostic capabilities. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the overall valuation of the US perfusion imaging market in 2024?** A: The overall market valuation was $1166.1 Million in 2024. **Q: What is the projected market valuation for the US perfusion imaging market by 2035?** A: The projected valuation for 2035 is $1748.62 Million. **Q: What is the expected CAGR for the US perfusion imaging market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 3.75%. **Q: Which companies are considered key players in the US perfusion imaging market?** A: Key players include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, and Fujifilm Holdings Corporation. **Q: What are the main segments of the US perfusion imaging market by type?** A: The main segments by type include Computed Tomography (C.T. Scan), Magnetic Resonance Imaging (MRI), and Nuclear Medicine. **Q: What were the valuations for Magnetic Resonance Imaging (MRI) in 2024?** A: The valuation for Magnetic Resonance Imaging (MRI) was $450.0 Million in 2024. **Q: What is the projected valuation for Myocardial Perfusion Imaging by 2035?** A: The projected valuation for Myocardial Perfusion Imaging by 2035 is $600.0 Million. **Q: How does the valuation of Ventilation Perfusion Imaging compare to other applications?** A: Ventilation Perfusion Imaging had a valuation of $350.0 Million in 2024, which is lower than Myocardial Perfusion Imaging. **Q: What is the valuation range for Nuclear Medicine in the US perfusion imaging market?** A: The valuation range for Nuclear Medicine is between $366.1 Million and $548.62 Million. **Q: What applications are included in the US perfusion imaging market?** A: Applications include Myocardial Perfusion Imaging, Ventilation Perfusion Imaging, and Functional Brain Imaging. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-perfusion-imaging-market-19501*